IOVA
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Iovance Biotherapeutics reports potential best-in-class clinical data for Lifileucel TIL cell therapy in advanced non-small cell lung cancerNov 3, 2025
- Iovance's Amtagvi® (lifileucel) receives Health Canada approval for advanced melanomaAug 19, 2025
- Iovance presents five-year data for Amtagvi (lifileucel) in advanced melanoma patients at ASCO Annual MeetingMay 22, 2025